Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting

Oral Microbiology and Immunology

Volumn 21, Issue 4, 2006, Pages 252-255

  Farah, C S ^a   Hu, Y ^a,c   Riminton, S ^b   Ashman, R B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cytokine; Knockout mice; Oral candidiasis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CELLULAR IMMUNITY; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FUNGAL COLONIZATION; GENE TARGETING; HISTOPATHOLOGY; IMMUNE RESPONSE; INFECTION SENSITIVITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OROPHARYNX CANDIDIASIS; PROTEIN FUNCTION; TH1 CELL; TH2 CELL; THRUSH;

ANIMALS; BRAIN; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DISEASE SUSCEPTIBILITY; FEMALE; FUNGEMIA; GENE TARGETING; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-4; KIDNEY; MICE; MICE, KNOCKOUT; MOUTH MUCOSA; PROTEIN SUBUNITS; SPECIFIC PATHOGEN-FREE ORGANISMS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748341711     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2006.00288.x     Document Type: Article

References (23)

1. Adorini L, Gregori S, Magram J, Trembleau Sn. The role of IL-12 in the pathogenesis of Th1 cell-mediated autoimmune diseases. Ann N Y Acad Sci 1996: 795: 208-215.
2. Ashman RB. Genetic determination of susceptibility and resistance in the pathogenesis of Candida albicans infection. FEMS Immunol Med Microbiol 1997: 19: 183-189.
3. Ashman RB, Farah CS, Wanasaengsakul S, Hu Y, Pang G, Clancy RL. Innate versus adaptive immunity in Candida albicans infection. Immunol Cell Biol 2004: 82: 196-204.
4. -/-) mice. J Infect Dis 1998: 178: 478-487.
5. Cantorna MT, Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 1991: 164: 936-943.
6. Cutler JE. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J Reticuloendothel Soc 1976: 19: 121-124.
7. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993: 259: 1739-1742.
8. Farah CS, Elahi S, Drysdale K et al. Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis. Infect Immun 2002: 70: 724-731.
9. Farah CS, Gotjamanos T, Seymour GJ, Ashman RB. Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol Immunol 2002: 17: 375-378.
10. Farah CS, Hong S, Wanasaengsakul S et al. Irradiation-induced oral candidiasis in an experimental murine model. Oral Microbiol Immunol 2001: 16: 358-363.
11. Fidel PL, Jr. Immunity to Candida. Oral Dis 2002: 8: 69-75.
12. Fidel PL, Jr, Sobel JD. The role of cell-mediated immunity in candidiasis. Trends Microbiol 1994: 2: 202-206.
13. Filler SG, Yeaman MR, Sheppard DC. Tumor necrosis factor inhibition and invasive fungal infections. Clin Infect Dis 2005: 41 (suppl 3): S208-S212.
14. Hu Y, Farah CS, Ashman RB. Isolates of Candida albicans that differ in virulence for mice elicit strain-specific antibody-mediated protective responses. Microbes Infect 2006: in press.
15. Kaposzta R, Tree P, Marodi L, Gordon S. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 1998: 66: 1708-1717.
16. Lilic D, Gravenor I, Robson N et al. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect Immun 2003: 71: 5690-5699.
17. Magram J, Connaughton S, Warrier R et al. IL-12 deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996: 4: 471-481.
18. Marino MW, Dunn A, Grail D et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A 1997: 94: 8093-8098.
19. Mahanty S, Greenfield RA, Joyce WA, Kincade PW. Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun 1988: 56: 3162-3166.
20. Mencacci A, Cenci E, Del Sero G et al. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. Int Immunol 1998: 10: 37-48.
21. Netea MG, van Tits LJ, Curfs JH et al. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 1999: 163: 1498-1505.
22. Qian Q, Cutler JE. Gamma interferon is not essential in host defense against disseminated candidiasis in mice. Infect Immun 1997: 65: 1748-1753.
23. Rogers TJ, Balish E, Manning DD. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc 1976: 20: 291-298.